Cigna Group
Revenue Breakdown
| Fiscal Year | Pharmacy Revenues | Premiums | Fees and Other Revenues | Net Investment Income | Realized Investment Gains (Losses) |
|---|---|---|---|---|---|
| FY2009 | $1.94B | $13.29B | $2.14B | $1.12B | $-82.0M |
| FY2010 | $2.13B | $15.63B | $2.30B | $1.15B | $43.0M |
| FY2011 | $2.06B | $16.37B | $2.34B | $1.14B | $81.0M |
| FY2012 | $3.00B | $21.99B | $2.91B | $1.14B | $93.0M |
| FY2013 | $3.18B | $24.67B | $3.25B | $1.15B | $129.0M |
| FY2014 | $3.37B | $26.80B | $3.46B | $1.18B | $112.0M |
| FY2015 | $3.72B | $29.11B | $3.75B | $1.18B | $116.0M |
| FY2016 | $4.19B | $30.14B | $4.06B | $1.22B | $79.0M |
| FY2017 | $4.50B | $31.35B | $4.37B | $1.28B | $112.0M |
| FY2018 | $3.84B | $37.29B | $5.70B | $1.38B | $435.0M |
| FY2019 | $87.42B | $48.15B | $16.08B | $1.60B | $328.0M |
| FY2020 | $98.34B | $44.70B | $14.85B | $1.33B | $1.37B |
| FY2021 | $110.68B | $42.28B | $18.92B | $1.42B | $880.0M |
| FY2022 | $120.49B | $40.66B | $18.01B | $1.22B | $-576.0M |
| FY2023 | $134.16B | $42.28B | $17.09B | $1.48B | $263.0M |